Potential Role of a Once-Daily Intravenous Non-Opioid Option

Thursday, November 5, 2020
12:30-2:30 p.m.
Baudax Bio, Inc.

Despite advances in surgical techniques over the past several decades, moderate to severe postoperative pain continues to be a widespread and unresolved healthcare problem. Guidelines for the management of postoperative pain recommend the use of multimodal analgesic treatment regimens that include around-the-clock non-opioid analgesics, specifically nonsteroidal anti-inflammatory drugs (NSAIDs). This program will feature a discussion about a once-daily intravenous (IV) NSAID. The discussion will include an overview of clinical trial data, and the potential role of this agent in multimodal analgesia for moderate to severe postoperative pain.

Review all Industry Symposia and register.

Close Bitnami banner